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ABSTRACT
We created Asthma e-Lab, a secure web-based research
environment to support consistent recording, description
and sharing of data, computational/statistical methods and
emerging ﬁndings across the ﬁve UK birth cohorts. The e-
Lab serves as a data repository for our uniﬁed dataset and
provides the computational resources and a scientiﬁc social
network to support collaborative research. All activities are
transparent, and emerging ﬁndings are shared via the e-
Lab, linked to explanations of analytical methods, thus
enabling knowledge transfer. eLab facilitates the iterative
interdisciplinary dialogue between clinicians, statisticians,
computer scientists, mathematicians, geneticists and basic
scientists, capturing collective thought behind the
interpretations of ﬁndings.
Asthma epidemiology is reaching the limit of what
can be achieved through conventional
hypothesis-driven research, due to factors that
include residual confounding, multiple inﬂuences of
modest effect size and lack of statistical power to
detect interactions between factors in complex data-
sets. Evidence is mounting that asthma is not a single
disease, but a collection of several diseases, each with
unique pathophysiology, and environmental and
genetic associates (often referred to as ‘asthma endo-
types’).1 Some reports have proposed abolishing the
term ‘asthma’.2 This conceptual framework of
‘asthma syndrome’ may also explain why
the responses to currently available treatments vary
considerably: if asthma is an umbrella diagnosis that
comprises multiple diseases with distinct mechan-
isms, then it is unlikely that these different diseases
would always respond equally to same therapeutic
agents. In this context, ‘asthma phenotype’ can be
viewed as an observable characteristic that can be
shared between several diseases (‘endotypes’) within
the asthma syndrome, while ‘asthma endotype’ is a
hypothetical construct that has a tangible value in
helping us to better understand the underlying patho-
physiological mechanisms of asthma disease-related
states and may help identify more effective persona-
lised treatment strategies. However, unless better
ways are found to distinguish between different
endotypes, it will be difﬁcult to discover their under-
lying pathophysiological processes or identify novel
therapeutic targets for stratiﬁed treatment, as any
signal will be diluted by phenotypical heterogeneity.1
Asthma usually starts early in life, and may pro-
gress, remit or relapse over time. Temporal analysis is
therefore crucial for distinguishing between different
subtypes of asthma, and the population-based birth
cohort (which overcomes recall bias and permits lon-
gitudinal phenotyping) is the preferred study design
for investigating this kind of disease development.3
Birth cohorts collectively may contain fundamentally
important data to elucidate true endotypes of child-
hood asthma. A major challenge for epidemiology is
how best to use the vast amount of data generated in
multiple birth cohorts, how to integrate different
scales of data (from molecular-level, genetic and epi-
genetic, to population-level variables and environ-
mental exposures) and different levels of directness
of measurement of the many variables of interest.
Pooling resources and multidisciplinary expertise
from different centres to maximise the potential of
gathered data may facilitate the improvement of
health outcomes (http://www.farrinstitute.org).
Ideally, researchers would use all available data (eg,
multiple questions, directly observed exposure and
outcome measures and laboratory readouts at mul-
tiple time points) to identify latent structure within
the data that may arise from different pathophysio-
logical processes underlying endotypes. Such models
need to be tailored to individual datasets and be able
to scale up to large volumes of data, taking into
account the time course of developmental proﬁles at
individual level. Rather than using a ‘black box’ or
‘data-mining’ approach, this process should be
informed by the current and future biological and
clinical knowledge about asthma. For example,
pathological and physiological processes can be
mapped out in computable forms using a technique
called graphical modelling, which creates annotated
dependency graphs of the underlying biological pro-
cesses. To do this effectively, it is essential to integrate
three key ingredients: (1) data, (2) models/methods
that can be tailored in full to the problem space and
(3) human expertise to tailor models/methods and
make sense of results in context. Bringing the data,
methods and investigators together on-line is one of
the key objectives of the Study Team for Early Life
Asthma Research (STELAR) consortium.
STELAR CONSORTIUM
In 2002, Asthma UK commissioned the creation of
a database of the UK-based birth cohorts focusing
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on asthma. Recognising their commonality of purpose, the
investigators from ﬁve birth cohorts (Avon Longitudinal Study
of Parents and Children, Ashford and Isle of Wight cohorts,
Manchester Asthma and Allergy Study and the Aberdeen Study
of Eczema and Asthma To Observe the Effects of Nutrition)
created the STELAR network. Individually, each cohort has great
depth in terms of exceptionally well-characterised subjects, a
wealth of environmental exposure measures and genetic and
other biological data. Collectively, the STELAR network gains
power from this breadth (data are available on >14 000 chil-
dren with many repeat measures over time). A further strength
is derived from the collaborative agreement to introduce harmo-
nised protocols to develop common outcomes, which facilitates
data pooling.
The STELAR consortium is truly multidisciplinary, combining
expertise in birth cohorts (the STELAR network), with molecu-
lar genetics, epidemiologically oriented health informatics
research and statistical machine learning, to capitalise on the
rich resource available within the cohorts.
STELAR Asthma e-Lab: a secure web-based resource for
managing the data, metadata and collaborative analysis
To carry out the analyses and apply a graphical modelling
approach to this large, complex dataset, the data must be access-
ible to the analysts, along with consistent information about the
study measurements and the assumptions underlying the rela-
tions reﬂected in the annotated dependency graphs representing
the problem space of asthma. To achieve this, we created a
secure web-based research environment (Asthma e-Lab; http://
www.asthmaelab.org) to support consistent recording, descrip-
tion and sharing of data, computational statistical methods and
emerging ﬁndings across the cohorts. The Asthma e-Lab serves
as a data repository populated with a uniﬁed dataset from our
well-deﬁned birth cohorts; in addition, it provides the computa-
tional resources and a scientiﬁc social network to support
timely, collaborative research across the consortium (ﬁgure 1).
The activities of data managers and investigators from the ﬁve
STELAR sites are visible to one another, supporting team coord-
ination and peer support, while creating a record of activity to
ensure transparency. Researchers inputting the data can see how
the data are being used in the analyses and receive on-line train-
ing via the e-Lab, thereby harmonising the relevant knowledge,
skills and practices needed to create a consistent STELAR
dataset. Emerging ﬁndings are shared with all sites via the
e-Lab, linked to explanations of analytical methods that might
not be familiar to all participants, thereby creating a scientiﬁc
social network enriching the ongoing modelling and
interpretation.
Mapping the study variables across the cohorts
Data managers from each cohort have mapped and annotated
the recorded variables across the studies consistently. This
mapping necessitates detailed descriptions (metadata) for each
variable. Details held on case report forms in all ﬁve cohorts are
quality assured through an online presubmission process before
incorporation into the research-ready dataset.
Managing data securely
The privacy of participants is fully protected through the use of
ﬁne-grained access control and removal of identiﬁable data
items, at the same time as opening up the analysis process to a
range of investigators across the project.
Managing research questions and performing analyses
The Asthma e-Lab assembles the relevant components of
research for each question in a ‘Research Object’, containing
data extracts, research protocols, statistical or machine learning
codes, annotated result logs, manuscripts and others. The code
behind each analysis is documented and linked to the data and
metadata for each variable involved.
Networking around results
Investigators can comment on results in near real time via the
e-Lab, facilitating timely discussion over the modelling. This, in
turn, leads to documented reﬁnements of model structure. In
addition, the chains of collective thought behind the interpreta-
tions of ﬁndings are captured. An online STELAR community is
nurtured to maximise the transfer of knowledge between differ-
ent areas of expertise. Some researchers are more familiar than
others with the analytical methods or pathophysiological
mechanisms around speciﬁc questions. The ‘scientiﬁc social
network of analysis’ created by the e-Lab maximises the poten-
tial insights that can be generated from the consortium as a
whole by enabling knowledge transfer that allows researchers to
access expertise invested in groups other than their own.
Audit trail
We preserve the raw data and the metadata required to repro-
duce each analysis. All discrete investigations (published and
unpublished) are thus easy to ﬁnd, share and reuse as ‘Research
Objects’, building on leading research into scientiﬁc knowledge
management.4 Our approach ensures that the methodologists
(statisticians, mathematicians and computer scientists) and
applied researchers (clinicians and basic scientists) share consist-
ent information about the data and methods used in speciﬁc
analyses. Analyses can easily be reproduced and shared between
investigators, at different sites, at all stages of analysis, since the
assumptions behind each analysis are recorded in a structured
way alongside the scripts that execute the calculations. In this
way, the data will be preserved in the contexts of the analyses,
making them available and accessible for use by external
researchers via Asthma e-Lab.
Access to e-Lab
The e-Lab engineers work with the Steering Committee to
enable different levels of sharing of data and analyses, ensuring
that the e-Lab technical infrastructure reﬂects the agreed
Figure 1 Study Team for Early Life Asthma Research (STELAR)
Asthma e-Lab: platform for uniform storage and interaction for UK birth
cohorts data. ALSPAC, Avon Longitudinal Study of Parents and
Children; ASHFORD, Ashford cohort (Kent); IOW, Isle of Wight cohort;
MAAS, Manchester Asthma and Allergy Study; SEATON, Study of
Eczema and Asthma To Observe the Effects of Nutrition (Aberdeen).








governance process. The future releases of the e-Lab will
include additional functionality and capacity for inclusion of
other cohorts.
THE INTERDISCIPLINARY DIALOGUE
The construction and running of this secure web-based resource
for managing the data, metadata and collaborative analysis will
encourage and facilitate the iterative interdisciplinary dialogue
between clinicians, statisticians, computer scientists, mathemati-
cians, geneticists and basic scientists, all working on a common
problem,5 a 21st-century ‘Team Science’. The successful comple-
tion of such a programme may enable us to determine true
asthma endotypes, to identify endotype-speciﬁc environmental
protective and susceptibility factors, and then for each asthma
endotype to discover speciﬁc biomarkers and identify target
pathways and molecules for drug discovery.
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